Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Wang, Hongjie  [Clear All Filters]
2024
He E, Sui H, Wang H, Zhao X, Guo W, Dai Z, Wu Z, Huang K, Zhao Q. Interleukin-19 in Bone Marrow Contributes to Bone Loss Via Suppressing Osteogenic Differentiation Potential of BMSCs in Old Mice. Stem Cell Rev Rep. 2024.
2023
Wang H, Georgakopoulou A, Zhang W, Kim J, Gil S, Ehrhardt A, Lieber A. HDAd6/35++ - A new helper-dependent adenovirus vector platform for transduction of hematopoietic stem cells. Mol Ther Methods Clin Dev. 2023;29:213-226.
Li C, Georgakopoulou A, Newby GA, Chen PJ, Everette KA, Paschoudi K, Vlachaki E, Gil S, Anderson AK, Koob T, et al. In vivo HSC prime editing rescues Sickle Cell Disease in a mouse model. Blood. 2023.
Dai Z, Chen Y, He E, Wang H, Guo W, Wu Z, Huang K, Zhao Q. Interleukin-19 promotes bone resorption by suppressing osteoprotegerin expression in BMSCs in a lipopolysaccharide-induced bone loss mouse model. Bone Joint Res. 2023;12(11):691-701.
2022
Wang Y, Zhang Y, Chen K, Liu J, Wu D, Cheng Y, Wang H, Li Y. Insufficient S-adenosylhomocysteine hydrolase compromises the beneficial effect of diabetic BMSCs on diabetic cardiomyopathy. Stem Cell Res Ther. 2022;13(1):418.
2020
Li C, Wang H, Georgakopoulou A, Gil S, Yannaki E, Lieber A. In Vivo HSC Gene Therapy Using a Bi-modular HDAd5/35++ Vector Cures Sickle Cell Disease in a Mouse Model. Mol Ther. 2020.
2019
Wang H, Liu Z, Li C, Gil S, Papayannopoulou T, Doering CB, Lieber A. High-level protein production in erythroid cells derived from in vivo transduced hematopoietic stem cells. Blood Adv. 2019;3(19):2883-2894.
2018
Wang H, Georgakopoulou A, Psatha N, Li C, Capsali C, Samal HBhusan, Anagnostopoulos A, Ehrhardt A, Izsvák Z, Papayannopoulou T, et al. In vivo hematopoietic stem cell gene therapy ameliorates murine thalassemia intermedia. J Clin Invest. 2018.